ChemicalBook--->CAS DataBase List--->57076-71-8

57076-71-8

57076-71-8 Structure

57076-71-8 Structure
IdentificationBack Directory
[Name]

DENBUFYLLINE
[CAS]

57076-71-8
[Synonyms]

brl30892
DENBUFYLLINE
1,3-DI-N-BUTYL-7-(2'-OXOPROPYL)XANTHINE
7-Acetonyl-1,3-dibutyl-3,7-dihydro-1H-purine-2,6-dione
3,7-dihydro-1,3-dibutyl-7-(2-oxopropyl)-1h-purine-6-dione
3,7-dihydro-1,3-dibutyl-7-(2-oxopropyl)-1h-purine-2,6-dione
1,3-Dibutyl-3,7-dihydro-7-(2-oxopropyl)-1H-purine-2,6-dione
[Molecular Formula]

C16H24N4O3
[MDL Number]

MFCD00867152
[MOL File]

57076-71-8.mol
[Molecular Weight]

320.39
Chemical PropertiesBack Directory
[Appearance]

White Solid
[Melting point ]

98-100°C
[storage temp. ]

Refrigerator
[solubility ]

DMSO, Methanol
[form ]

Solid
[color ]

Off-White to Pale Beige
[CAS DataBase Reference]

57076-71-8
Hazard InformationBack Directory
[Chemical Properties]

White Solid
[Uses]

A cell permeable xanthine derivatvie that acts as a selective inhibitor of phosphodiesterase IV (PDE IV). Possesses bronchodilatory properties. Displays negative inotropic effect by acting on a verapamil-sensitive site of the calcium channel in guinea pig ventricle apaillary muscle independently of its PDE inhibitory activity.
[Uses]

Bronchial spasmolysis agent
[Description]

Denbufylline, a xanthine derivative and PDE4 inhibitor, has effects such as vasodilatation of cerebral vessels (Willette et al., 1997) and potent activation of the hypothalamic–pituitary–adrenal axis. PDE4 is one of the cyclic adenosine monophosphate (cAMP)–specic phosphodiesterases whose tissue distribution is important in pathologies related to the central nervous and immune systems. In experimental animals, denbufylline increases adrenocorticotropic hormone (ACTH), circulating corticosterone, luteinizing hormone, corticotrophin-releasing hormone, and cAMP content of the hypothalamic tissue, but is without effect on arginine vasopressin (Kumari et al., 1997). Treves and Korczyn (1999) studied patients with AD, mixed dementia, and VaD treated with denbufylline. No signicant differences were found in comparison with placebo for the treatment of AD or VaD, although patients who received denbufylline tended to improve their cognitive scores.
[Definition]

ChEBI: 1,3-dibutyl-7-(2-oxopropyl)purine-2,6-dione is an oxopurine.
57076-71-8 suppliers list
Company Name: J & K SCIENTIFIC LTD.  
Telephone: 18210857532 18210857532
Website: https://www.jkchemical.com
Company Name: Chemsky(shanghai)International Co.,Ltd.  
Telephone: 021-50135380
Website: www.shchemsky.com
Company Name: Shanghai TaoSu Biochemical Technology Co., Ltd.  
Telephone: 021-33632979
Website: www.tsbiochem.com
Company Name: Shenzhen Polymeri Biochemical Technology Co., Ltd.  
Telephone: +86-400-002-6226
Website: https://www.rrkchem.com
Company Name: Guangzhou Younan Technology Co., Ltd  
Telephone: 020-82000279 18988941452
Website: http://www.ubiochem.cn/
Company Name: Foshan Treasure Biotechnology Co., Ltd  
Telephone: 0757-85921206 18520245316
Website: http://www.fsbn-bio.com/
Company Name: TargetMol Chemicals Inc.  
Telephone: 15002134094
Website: https://www.targetmol.cn/
Company Name: LGC Science (Shanghai) Ltd.  
Telephone: 17717235263 17717235263
Website: www.lgcstandards.com/cn/en/
Tags:57076-71-8 Related Product Information
58-55-9 31542-63-9